Recycled Material Art Challenge Auction
If you see an auction item you want to keep track of, you can add it to a Watch list. You will receive an email when a bid is entered for an item on your Watch list. Click here to set up your Watch
If you see an auction item you want to keep track of, you can add it to a Watch list. You will receive an email when a bid is entered for an item on your Watch list. Click here to set up your Watch
The FDA has granted orphan drug designation to azeliragon as a potential therapeutic option for patients with pancreatic cancer.
Routine cognitive testing may help older drivers plan for life after driving
Inavolisib/palbociclib/fulvestrant was granted FDA granted breakthrough therapy designation for PIK3CA-mutated, HR-positive/HER2-negative breast cancer.
S. Vincent Rajkumar, MD, discusses highly anticipated abstracts in multiple myeloma that will be presented at the 2024 ASCO Annual Meeting.
Yi-Bin Chen leads the panel in a review of various GVHD prophylaxis regimens.
Douglas W. Sborov, MD, MS, presents the case of a 54-year-old woman with newly diagnosed multiple myeloma.
Ashwin Kishtagari, MD, discusses the investigation of JAK inhibitor–based combinations in myelofibrosis.
Peter H. O’Donnell, MD, provides insights on key developments in bladder cancer management and how they have generated optimism within the field.
Smoking is a major driver for bladder cancer. Now, a new treatment has come to Philadelphia to help more patients maintain their quality of life.
An abstract is unavailable.